Showing results (1611-1620 of 6,360) with videos related to
Sort By:
Pageof 636
Clinical Ophthalmology (Auckland, N.Z.)|October 17, 2018
Long-term outcomes of intended undercorrection intraocular lens implantation in pediatric cataractApatsa Lekskul, Pichaya Chuephanich, Chao CharoenkijkajornClinical Ophthalmology (Auckland, N.Z.)|October 17, 2018
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye diseaseJoseph Tauber, Barry A Schechter, Jason Bacharach, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 17, 2018
Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to dateLily Dasso, Tala Al-Khaled, Sriram Sonty, et al.Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2016
Genetics and age-related macular degeneration: a practical review for the clinicianStephen G Schwartz, Blake M Hampton, Jaclyn L Kovach, et al.Clinical Ophthalmology (Auckland, N.Z.)|May 2, 2015
Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trialPeter A Simmons, Cindy Carlisle-Wilcox, Joseph G VehigeClinical Ophthalmology (Auckland, N.Z.)|May 2, 2015
Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trialPeter A Simmons, Haixia Liu, Cindy Carlisle-Wilcox, et al.Clinical Ophthalmology (Auckland, N.Z.)|May 2, 2015
A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)Ioannis M Aslanides, Vasilis D Selimis, Nikolaos V Bessis, et al.Clinical Ophthalmology (Auckland, N.Z.)|May 1, 2015
Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazoleKopal Mithal, Avinash Pathengay, Abhishek Bawdekar, et al.Clinical Ophthalmology (Auckland, N.Z.)|April 28, 2015
Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye dropsKenji Inoue, Minako Shiokawa, Kyoko Ishida, et al.Clinical Ophthalmology (Auckland, N.Z.)|July 17, 2020
The Role of Time Exposed to Outdoor Light for Myopia Prevalence and Progression: A Literature ReviewLeila Sara Eppenberger, Veit SturmPageof 636